Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons

Brain Research Bulletin

Volumn 88, Issue 5, 2012, Pages 487-494

  Shen, Wenjuan ^a,b,c   Qi, Renbin ^a,b,c   Zhang, Jing ^a,b,c   Wang, Zhigang ^a,b,c   Wang, Huadong ^a,b,c   Hu, Chaofeng ^a,b,c   Zhao, Yanru ^a,b,c   Bie, Man ^a,b,c   Wang, Yanping ^a,b,c   Fu, Yongmei ^a,b,c   Chen, Mengfei ^d   Lu, Daxiang ^a,b,c  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c Third Grade Laboratory of the State Administration of Traditional Chinese Medicine   (China)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chlorogenic acid; Lipopolysaccharide; Microglia; Neuroinflammation; Nuclear factor B

Indexed keywords

CD11B ANTIGEN; CHLOROGENIC ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; IN VIVO STUDY; MICROGLIA; MOUSE; NERVE CELL STIMULATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SUBSTANTIA NIGRA;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHLOROGENIC ACID; DOPAMINERGIC NEURONS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA;

EID: 84862569354     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.04.010     Document Type: Article

References (47)

1. Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169.
2. Arai H., Furuya T., Yasuda T., Miura M., Mizuno Y., Mochizuki H. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice. Journal of Biological Chemistry 2004, 279:51647-51653.
3. Arimoto T., Choi D.Y., Lu X., Liu M., Nguyen X.V., Zheng N., Stewart C.A., Kim H.C., Bing G. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiology of Aging 2007, 28:894-906.
4. Barres B.A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 2008, 60:430-440.
5. Block M.L., Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Progress in Neurobiology 2005, 76:77-98.
6. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience 2007, 8:57-69.
7. Burguillos M.A., Deierborg T., Kavanagh E., Persson A., Hajji N., Garcia-Quintanilla A., Cano J., Brundin P., Englund E., Venero J.L., Joseph B. Caspase signalling controls microglia activation and neurotoxicity. Nature 2011, 472:319-324.
8. Delgado M., Jonakait G.M., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia. Glia 2002, 39:148-161.
9. Dello Russo C., Boullerne A.I., Gavrilyuk V., Feinstein D.L. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. Journal of Neuroinflammation 2004, 1:9.
10. Fan R., Xu F., Previti M.L., Davis J., Grande A.M., Robinson J.K., Van Nostrand W.E. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. Journal of Neuroscience 2007, 27:3057-3063.
11. Feng R., Lu Y., Bowman L.L., Qian Y., Castranova V., Ding M. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. Journal of Biological Chemistry 2005, 280:27888-27895.
12. Gao H.M., Liu B., Zhang W., Hong J.S. Novel anti-inflammatory therapy for Parkinson's disease. Trends in Pharmacological Sciences 2003, 24:395-401.
13. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001, 25:386-401.
14. Guix F.X., Uribesalgo I., Coma M., Munoz F.J. The physiology and pathophysiology of nitric oxide in the brain. Progress in Neurobiology 2005, 76:126-152.
15. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neuroscience 2007, 10:1387-1394.
16. Huang S.M., Chuang H.C., Wu C.H., Yen G.C. Cytoprotective effects of phenolic acids on methylglyoxal-induced apoptosis in neuro-2A cells. Molecular Nutrition & Food Research 2008, 52:940-949.
17. Ionescu V.A., Villanueva E.B., Hashioka S., Bahniwal M., Klegeris A. Cultured adult porcine astrocytes and microglia express functional interferon-gamma receptors and exhibit toxicity towards SH-SY5Y cells. Brain Research Bulletin 2011, 84:244-251.
18. Ito H., Sun X.L., Watanabe M., Okamoto M., Hatano T. Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Bioscience, Biotechnology, and Biochemistry 2008, 72:885-888.
19. Katsuki H., Kurimoto E., Takemori S., Kurauchi Y., Hisatsune A., Isohama Y., Izumi Y., Kume T., Shudo K., Akaike A. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling. Journal of Neurochemistry 2009, 110:707-718.
20. Kawai T., Akira S. Signaling to NF-kappaB by toll-like receptors. Trends in Molecular Medicine 2007, 13:460-469.
21. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. Journal of Neuroscience 2000, 20:6309-6316.
22. Kim H.R., Lee D.M., Lee S.H., Seong A.R., Gin D.W., Hwang J.A., Park J.H. Chlorogenic acid suppresses pulmonary eosinophilia, IgE production, and Th2-type cytokine production in an ovalbumin-induced allergic asthma: activation of STAT-6 and JNK is inhibited by chlorogenic acid. International Immunopharmacology 2010, 10:1242-1248.
23. Kovacs Z., Czurko A., Kekesi K.A., Juhasz G. Intracerebroventricularly administered lipopolysaccharide enhances spike-wave discharges in freely moving WAG/Rij rats. Brain Research Bulletin 2011, 85:410-416.
24. Krakauer T. The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacology and Immunotoxicology 2002, 24:113-119.
25. Kwon S.H., Lee H.K., Kim J.A., Hong S.I., Kim H.C., Jo T.H., Park Y.I., Lee C.K., Kim Y.B., Lee S.Y., Jang C.G. Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. European Journal of Pharmacology 2010, 649:210-217.
26. Lee J.K., McCoy M.K., Harms A.S., Ruhn K.A., Gold S.J., Tansey M.G. Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response. Journal of Neuroscience 2008, 28:8517-8528.
27. Lee J.H., Park J.H., Kim Y.S., Han Y. Chlorogenic acid a polyphenolic compound, treats mice with septic arthritis caused by Candida albicans. International Immunopharmacology 2008, 8:1681-1685.
28. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury. Glia 2009, 58:253-263.
29. Li S., Bian H., Liu Z., Wang Y., Dai J., He W., Liao X., Liu R., Luo J. Chlorogenic acid protects MSCs against oxidative stress by altering FOXO family genes and activating intrinsic pathway. European Journal of Pharmacology 2012, 674:65-72.
30. Lleo A., Galea E., Sastre M. Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases. Cellular and Molecular Life Sciences 2007, 64:1403-1418.
31. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. Journal of Clinical Investigation 2001, 107:247-254.
32. McCoy M.K., Tansey M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. Journal of Neuroinflammation 2008, 5:45.
33. Memet S. NF-kappaB functions in the nervous system: from development to disease. Biochemical Pharmacology 2006, 72:1180-1195.
34. Mizuno T., Kuno R., Nitta A., Nabeshima T., Zhang G., Kawanokuchi J., Wang J., Jin S., Takeuchi H., Suzumura A. Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes. Brain Research 2005, 1066:78-85.
35. Monsonego A., Weiner H.L. Immunotherapeutic approaches to Alzheimer's disease. Science 2003, 302:834-838.
36. Park H.J., Lee P.H., Ahn Y.W., Choi Y.J., Lee G., Lee D.Y., Chung E.S., Jin B.K. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. European Journal of Neuroscience 2007, 26:79-89.
37. Perry R.T., Collins J.S., Wiener H., Acton R., Go R.C. The role of TNF and its receptors in Alzheimer's disease. Neurobiology of Aging 2001, 22:873-883.
38. Qian L., Wu H.M., Chen S.H., Zhang D., Ali S.F., Peterson L., Wilson B., Lu R.B., Hong J.S., Flood P.M. Beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. Journal of Immunology 2011, 186:4443-4454.
39. Saura J., Tusell J.M., Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189.
40. Smith J.A., Das A., Ray S.K., Banik N.L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Research Bulletin 2011, 87:10-20.
41. Soliman K.F., Mazzio E.A. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proceedings of the Society for Experimental Biology and Medicine 1998, 218:390-397.
42. Szelenyi J., Kiss J.P., Vizi E.S. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. Journal of Neuroimmunology 2000, 103:34-40.
43. Szelenyi M., Laszlo Z., Szabo Z., Kromplak Z., Tischler E., Lakatos M., Szekely L. Hypothermia down-regulates the LPS-induced norepinephrine (NE) release in ischaemic human heart cells. Brain Research Bulletin 2012, 87:67-73.
44. Wang M.J., Lin S.Z., Kuo J.S., Huang H.Y., Tzeng S.F., Liao C.H., Chen D.C., Chen W.F. Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. Journal of Immunology 2007, 179:6204-6214.
45. Xu Y., Chen J., Yu X., Tao W., Jiang F., Yin Z., Liu C. Protective effects of chlorogenic acid on acute hepatotoxicity induced by lipopolysaccharide in mice. Inflammation Research 2010, 59:871-877.
46. Yun N., Kang J.W., Lee S.M. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. The Journal of Nutritional Biochemistry 2011, (Epub ahead of print).
47. Zhang X., Huang H., Yang T., Ye Y., Shan J., Yin Z., Luo L. Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury. Injury 2011, 41:746-752.